European Archives - Page 642 of 1060 - European Medical Journal

Continue
1 Mins
14 Nov 2019

What Do Patients Want in an Asthma App?

Asthma is estimated to affect 300 million people worldwide,1 and the literature advocates the beneficial effect of self-management programmes…
4 Mins
14 Nov 2019

Malignant Mesothelioma Presenting After Resolution of a Seemingly Benign Asbestos Related Pleural Effusion

This paper highlights the importance of ongoing follow-up in a patient with a label of benign asbestos-related pleural effusion.
3 Mins
14 Nov 2019

Unilateral Right Exophthalmia Revealing Systemic Sarcoidosis: A Case Report and a Review of the Literature
1 Mins
14 Nov 2019

Lung and Eye Pathology Develop Concurrently in a Neonatal Supplemental Oxygen Model

Bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) are two severe disorders that arise…
5 Mins
14 Nov 2019

A Case of Empyema and a Review of Practice in a District General Hospital

The Northumbria Healthcare NHS Foundation Trust serves just over half a million people across four different sites. There is a well-established…
1 Mins
14 Nov 2019

Obstructive Sleep Apnea and Objective Sleep Quality in Non-Dialysed Patients with Chronic Kidney Disease: An European Sleep Apnea Database (ESADA) Study

Short sleep duration and poor sleep quality have been reported in chronic kidney disease (CKD). Additionally, sleep disordered breathing (SDB)…
1 Mins
14 Nov 2019

Changes in Biomarkers in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib and Sildenafil

Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). Sildenafil is a phosphodiesterase-5…
2 Mins
14 Nov 2019

A Respiratory Review of Australian Men with Coal Mine Dust Lung Disease

In Queensland, Australia, coal mining is a large industry in terms of both employment and economy…
14 Mins
14 Nov 2019

Asthma in Children Under 5 Years in Rural Kyrgyzstan: A Diagnostic Vacuum? a Qualitative FRESH AIR Study

Worldwide, asthma is the most frequent non-communicable disease in childhood, often starting in infancy.
1 Mins
14 Nov 2019

Retrospective Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort

Latest guidelines in pulmonary arterial hypertension (PAH) recommend the use of multi-parameter risk assessment at both diagnosis…